NCT04312698 - Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 29, 2019

Primary Completion Date

June 18, 2021

Study Completion Date

June 18, 2021

Conditions

Dyslipidemia Patients With Hypertension

Interventions

DRUG

D013, D326, D337

Experimental: Group 1 Patients assigned to this group are treated with D013, D326, D337

DRUG

placebo of D013, D326, D337

Placebo Comparator: Group 1 Patients assigned to this group are treated with D326, D337, placebo of D013

DRUG

D013, placebo of D326, placebo of D337

Placebo Comparator: Group 2 Patients assigned to this group are treated with D013, placebo of D326, placebo of D337

Trial Locations (1)

Yonsei University Medical Center Severance Hospital, Seoul